ANP

3.53%

8.2¢

ANTISENSE THERAPEUTICS LIMITED

Market Cap $54.84M Add to my watchlist

RCE'S BREATHROUGH

Recce Pharmaceutical’s continues to advance their breakthrough anti-resistant antibiotic, R327. RCE is hoping this will be a world first for the treatment of deadly sepsis. RCE CEO, James Graham, discusses the medical crisis and critical need for R327.

Latest Threads

Tag

Subject

ANP

For General Information

12 13 14

00:54

819

179K

00:54

Last post Moreforme

819

179K

ANP

Ann: ANP to Present at the PPMD Annual Conference 2022

28/06/22

11K

28/06/22

Last post ANPto2Dollars

11K

ANP

Ann: Proteomics and disease marker identification in DMD Webinar

28/06/22

593

28/06/22

Last post arjay

593

ANP

Sarepta stumbles!

27/06/22

839

27/06/22

Last post RYNZN

839

ANP

Ann: Presentation at 2nd Annual Oligonucleotide for CNS Summit

25/06/22

4.6K

25/06/22

Last post Vinceanna

4.6K

ANP

Ann: New Indication for ATL1102 Limb Girdle Muscular Dystrophy R2

24/06/22

16K

24/06/22

Last post cdoyle

16K

ANP

Ann: Long COVID-19 strategic collaboration with US Experts

2 3 4

16/06/22

224

53K

16/06/22

Last post Suwang

224

53K

ANP

Ann: Positive UK PIP Decision & PDCO opinion ratification by EMA

11/06/22

8.1K

11/06/22

Last post dalts66

8.1K

See All Discussions

Timeline

Proteomics and disease marker identification in DMD Webinar
28 Jun 16:57	Share

ANP to Present at the PPMD Annual Conference 2022
24 Jun 09:30	Share

New Indication for ATL1102 Limb Girdle Muscular Dystrophy R2
20 Jun 09:34	Share

Presentation at 2nd Annual Oligonucleotide for CNS Summit
15 Jun 09:07	Share

Investor Presentation
27 May 09:37	Share

Bonus Options Issue - Letter to Shareholders
29 Apr 16:48	Share

Change of Director's Interest Notice (CG,MD)
29 Apr 16:40	Share

Notification regarding unquoted securities - ANP
28 Apr 11:47	Share

Quarterly Activities/Appendix 4C Cash Flow Report
28 Apr 09:30	Share

Receipt of R&D Tax Incentive Payment
14 Apr 08:46	Share

Proposed issue of securities - ANP
12 Apr 09:28	Share

Prospectus
12 Apr 09:22	Share

Bonus Option Offer
12 Apr 09:20	Share

Plasma protein data supports bone density improvement in DMD
14 Mar 09:19	Share

Poster Presentation at 2022 MDA Conference
01 Mar 12:12	Share

Long COVID-19 strategic collaboration with US Experts
24 Feb 12:54	Share

Half Yearly Report and Accounts
23 Feb 17:36	Share

ANP to present at XIX International Conference on DMD
17 Feb 12:03	Share

Dosing commenced in MCRI collaboration animal study
08 Feb 09:31	Share

Cleansing Notice
28 Jan 09:00	Share

Application for quotation of securities - ANP
28 Jan 08:57	Share

Proposed issue of securities - ANP
27 Jan 16:17	Share

Quarterly Report and Appendix 4C
27 Jan 09:11	Share

Cleansing Notice
24 Dec 12:19	Share

Application for quotation of securities - ANP
24 Dec 12:14	Share

Proposed issue of securities - ANP
23 Dec 16:58	Share

Change of Director's Interest Notice (MD)
22 Dec 10:02	Share

Notification regarding unquoted securities - ANP
22 Dec 09:56	Share

Application for quotation of securities - ANP
22 Dec 09:55	Share

Entitlement Offer Results
22 Dec 09:50	Share

View More

(20min delay) Trade with IG
Last 8.2¢		Change -0.003(3.53%)		Mkt cap ! $54.84M

Open	High	Low	Value	Volume
8.5¢	8.5¢	8.2¢	$53.89K	647.9K

Buyers (Bids)

No.	Vol.	Price($)
2	600000	8.1¢

Sellers (Offers)

Price($)	Vol.	No.
8.3¢	14024	1

View Market Depth

No.	Vol.	Price($)
2	600000	0.081
7	658862	0.080
1	75000	0.079
1	12750	0.078
2	60000	0.076

Price($)	Vol.	No.
0.083	14024	1
0.084	20000	1
0.086	68000	1
0.087	5600	1
0.088	13455	1

Last trade - 16.10pm 28/06/2022 (20 minute delay)

(live)
Last 8.1¢		Change -0.003 ( 3.57 %)
Open	High	Low	Volume
8.3¢	8.4¢	8.1¢	180182
Last updated 15.11pm 28/06/2022 (live) ?

ANP (ASX) Chart